logo
  

Novartis Plans New $15 Bln Share Buyback To Be Executed By 2023-end

Swiss drug maker Novartis (NVS) announced Thursday that it will initiate a share buyback of up to $15 billion to be executed by the end of 2023, highlighting confidence in top line growth and deep pipeline.

The company further said an additional 10 billion Swiss francs buyback authority will be sought at the forthcoming Annual General Meeting on March 4, 2022. This is to cover the amount exceeding the 8.8 billion francs still available under the existing shareholder authority granted in 2021.

The latest buyback is funded through the proceeds from the recent sale of 53.3 million Roche bearer shares.

The share buy-back will be executed on the 2nd trading line, is expected to commence in the coming days and to conclude by the end of 2023.

Novartis will provide further information on the growing dividend and growth outlook at the company's full year 2021 results on February 2nd, 2022.

The company said sales expected to grow 4%+ CAGR through 2026 and up to 20 new assets with significant sales potential set to potentially be approved by 2026, to fuel further growth through 2030 and beyond.

The company said, "With strong operational performance, prospects for earnings growth and the proceeds from the recent sale of the Roche stake, Novartis retains the flexibility to return value to shareholders through the planned USD 15bn share buyback, without compromising the company's capacity for value-creating bolt-on M&A, whilst providing a strong, growing dividend and reinvesting in the business."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration or FDA has urged infant formula manufacturers to import infant formula products to the United States to meet the ongoing severe supply shortage. In order to further increase the availability of infant formula in the country, while protecting the health of infants, the regulator announced a guidance outlining increased flexibilities for the global manufacturers Retail giant Walmart Inc. reported Tuesday a profit for the first quarter of fiscal 2023 that declined 24.8 percent from last year, hurt by lower gross margins and net losses on equity investments. Adjusted earnings per share also missed analysts' expectations, but quarterly revenues topped it. The retailer also cut its earnings guidance for the second quarter and for the full-year 2023. Billionaire and Tesla CEO Elon Musk, who is in deal to acquire Twitter Inc., may seek a lower price for the social media platform as he estimates that there could be at least four times more fake accounts than what the company informed, Reuters reported. It was in late April that Twitter agreed to accept Musk's about $44 billion takeover offer and to become a privately held company.
Follow RTT